DIC

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 20

Disseminated

Intravascular
Coagulation (DIC)
Dr Muhammad Javed Asif
• DIC is also designated as
Acquired Consumptive
Coagulopathy
Definition
An acquired syndrome characterized by

• Intravascular activation of coagulation with loss of


localization.

• Arises from different causes.


DIC
6
• Systemic intravascular
coagulation Thrombosis

• Coagulation is always Platelet


the initial event. Red Blood Cell

• Severity depends on
extent of intravascular Fibrin
thrombosis
Etiology
 Sepsis/ Severe infections:
 Trauma:
 Organ destruction:
- Severe pancreatitis
 Malignancies:
• Solid Tumors
• Leukaemias,
*Acute Promyelocytic ( AML-M3) /APML.
• Lymphoproliferative disorders
• Myeloproliferative syndromes
Etiology
Obstetrical Causes:
• Amniotic fluid embolism
• Abruptio placenta (premature separation of placenta)
• Septic abortion
• Retained products of conception
• HELLP syndrome (Haemolysis Elevated Liver enzymes & Low
Platelets)
Severe toxic or immunological reactions:
• Snake bites
• Transfusion reactions
• Transplant rejection
• drugs
Etiology
Massive blood loss with inadequate fluid
replacement therapy
Severe hepatic failure
Vascular abnormalities
Severe burns
Pathophysiology of DIC
1. Activation of Blood Coagulation
2. Suppression of Physiologic Anticoagulant Pathways
3. Impaired Fibrinolysis
4. Cytokines
Pathophysiology
of DIC

1. Activation of Blood Coagulation


• Tissue factor/factor VII a mediated thrombin generation via the extrinsic
pathway
• Activates factor IX and X
• TF can be generated by;
• endothelial cells
• monocytes
• Extravascular:
• lung
• kidney
• epithelial cells
Pathophysiology
of DIC

2. Suppression of Physiologic Anticoagulant Pathways


• Reduced antithrombin III levels
• Reduced activity of the protein C-protein S system
• Insufficient down regulation of tissue factor activity by Tissue
Factor Pathway Inhibitor (TFPI)*

*TFPI inhibits TF/FVIIa/Fxa complex activity


Pathophysiology
of DIC

3. Impaired Fibrinolysis
• relatively suppressed at time of maximal
activation of coagulation due to increased
Plasminogen Activator Inhibitor Type 1
Pathophysiology of
DIC

4. Cytokines ( IL-1, IL-6, IL-10 & TNF- )


• IL-6, and IL-1 mediates coagulation activation in DIC
• TNF-
• mediates dysregulation of physiologic anticoagulant pathways and
fibrinolysis
• modulates IL-6 activity
• IL-10 may modulate the activation of coagulation.

Inflamation Coagulation
DIC

SYSTEMIC ACTIVATION OF
COAGULATION

Intravascular Depletion of platelets


deposition of fibrin and coagulation
factors

Thrombosis of small and Bleeding


midsize vessels

Multiple Organ failure DEATH


Investigations
• CBC
• Anaemia (variable)
• Platelet count ?
• Peripheral Smear ?
• Coagulation Profile
• PT ?
• APTT ?
• Serum Fibrinogen ?
• Fibrinogen degradation products ( FDP’s) ?
• D-Dimers ?
Investigations
• CBC
• Anaemia (variable)
• Platelet count (decreased)
• Peripheral Smear (RBC fragmentation)
• Coagulation Profile
• PT (prolonged)
• APTT (prolonged)
• Serum Fibrinogen (depletion)
• Fibrinogen degradation products (FDP’s) (increased)
• D-Dimers (increased)
Microscopic findings in
DIC
• Fragments
(Schistocytes)

• Paucity of
platelets
Schistiocytes

You might also like